GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ObsEva SA (CHIX:OBSNz) » Definitions » Ending Cash Position

ObsEva (CHIX:OBSNZ) Ending Cash Position : CHF13.94 Mil (As of Dec. 2022)


View and export this data going back to 2018. Start your Free Trial

What is ObsEva Ending Cash Position?

ObsEva's Ending Cash Position for the quarter that ended in Dec. 2022 was CHF13.94 Mil.

ObsEva's quarterly Ending Cash Position declined from Jun. 2022 (CHF43.78 Mil) to Sep. 2022 (CHF9.43 Mil) but then increased from Sep. 2022 (CHF9.43 Mil) to Dec. 2022 (CHF13.94 Mil).

ObsEva's annual Ending Cash Position increased from Dec. 2020 (CHF27.70 Mil) to Dec. 2021 (CHF50.41 Mil) but then declined from Dec. 2021 (CHF50.41 Mil) to Dec. 2022 (CHF13.94 Mil).


ObsEva Ending Cash Position Historical Data

The historical data trend for ObsEva's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ObsEva Ending Cash Position Chart

ObsEva Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only 137.52 68.16 27.70 50.41 13.94

ObsEva Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.41 53.49 43.78 9.43 13.94

ObsEva Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

ObsEva's Ending Cash Position for the fiscal year that ended in Dec. 2022 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=50.99+-37.055
=13.94

ObsEva's Ending Cash Position for the quarter that ended in Dec. 2022 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=9.022+4.913
=13.94


ObsEva Ending Cash Position Related Terms

Thank you for viewing the detailed overview of ObsEva's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


ObsEva (CHIX:OBSNZ) Business Description

Traded in Other Exchanges
N/A
Address
Chemin des Aulx, 12, Plan-les-Ouates, Geneva, CHE, 1228
ObsEva SA is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. The Company operates in one segment, which is the research and development of innovative women's reproductive, health, and pregnancy therapeutics. It includes advancing a development program for Nolasiban, an oral oxytocin receptor agonist, focused on improving clinical pregnancy and live birth rates in women undergoing in-vitro fertilization (IVF). Geographically, the majority is from Switzerland.

ObsEva (CHIX:OBSNZ) Headlines

No Headlines